Skip to main content
. 2021 Jul 1;13(7):1002. doi: 10.3390/pharmaceutics13071002

Figure 2.

Figure 2

Impact of therapeutic ultrasound application on amyloid pathology. SUS+MB facilitates the uptake of blood-borne factors, which activate microglia. These take up the amyloid into their lysosomes and digest it. Amyloid clearance and cognitive functions are improved when SUS+MB is combined with an analogue of the anti-amyloid-β antibody aducanumab (SUS+MB+ aducanumab analogue). Created with BioRender.com.